Innoviva, Inc.
INVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080014
No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Innoviva, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 193
- −4 vs. Q2 2023
- Shares held
- 68.3M
- −2.06M (−2.9%) vs. Q2 2023
- Total value
- $892.4M
- −$3.29M (−0.4%) vs. Q2 2023
- New holders
- 17
- 61 more added
- Sold out
- 21
- 88 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 308 | $1.69B |
| Q1 2026 | 285 | $1.76B |
| Q4 2025 | 280 | $1.50B |
| Q3 2025 | 263 | $1.38B |
| Q2 2025 | 266 | $1.47B |
| Q1 2025 | 247 | $1.24B |
| Q4 2024 | 236 | $1.24B |
| Q3 2024 | 221 | $1.41B |
| Q2 2024 | 213 | $1.20B |
| Q1 2024 | 216 | $1.11B |
| Q4 2023 | 197 | $1.16B |
| Q3 2023 | 193 | $892.4M |
| Q2 2023 | 198 | $898.1M |
| Q1 2023 | 193 | $789.0M |
| Q4 2022 | 208 | $1.01B |
| Q3 2022 | 213 | $901.8M |
| Q2 2022 | 219 | $1.17B |
| Q1 2022 | 236 | $1.49B |
| Q4 2021 | 218 | $1.23B |
| Q3 2021 | 208 | $1.18B |
| Q2 2021 | 184 | $939.5M |
| Q1 2021 | 177 | $842.1M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Innoviva, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meritage Portfolio Management | 0 | $0 | 0.00% | −31,266−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −25,213−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −22,478−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,470−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,619−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −11,064−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,217−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −4,579−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| 25 LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| EA Series Trust | – | – | – | – | Not filed |